DLBCL

Open Access
Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC Trial
Kibrom B. Girum, Anne-Ségolène Cottereau, Laetitia Vercellino, Louis Rebaud, Jérôme Clerc, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont and Irène Buvat

Journal of Nuclear Medicine February 1, 2024, 65 (2) 313-319; DOI: https://doi.org/10.2967/jnumed.123.266322
You have access
Prognostic Value of ¹⁸F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study
Thomas Carlier, Gauthier Frécon, Diana Mateus, Mira Rizkallah, Françoise Kraeber-Bodéré, Salim Kanoun, Paul Blanc-Durand, Emmanuel Itti, Steven Le Gouill, René-Olivier Casasnovas, Caroline Bodet-Milin and Clément Bailly

Journal of Nuclear Medicine January 1, 2024, 65 (1) 156-162; DOI: https://doi.org/10.2967/jnumed.123.265872
Open Access
¹⁸F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
Kibrom B. Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont and Irène Buvat

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1925-1932; DOI: https://doi.org/10.2967/jnumed.121.263501
You have access
¹⁸F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study
Coreline N. Burggraaff, Jakoba J. Eertink, Pieternella J. Lugtenburg, Otto S. Hoekstra, Anne I.J. Arens, Bart de Keizer, Martijn W. Heymans, Bronno van der Holt, Sanne E. Wiegers, Simone Pieplenbosch, Ronald Boellaard, Henrica C.W. de Vet, Josée M. Zijlstra and on behalf of the HOVON Imaging Working Group and the HOVON Lymphoma Working Group

Journal of Nuclear Medicine July 1, 2022, 63 (7) 1001-1007; DOI: https://doi.org/10.2967/jnumed.121.262205
You have access
Combined Visual and Semiquantitative Evaluation Improves Outcome Prediction by Early Midtreatment ¹⁸F-FDG PET in Diffuse Large B-Cell Lymphoma
Tamás Györke, Robert Carr, Juliano J. Cerci, Claudio Meneghetti, Francisca Redondo, Monica Celli, Charity Gorospe, Chirayu U. Auewarakul, Linda Jorgov, Diana Paez and Stefano Fanti

Journal of Nuclear Medicine July 1, 2020, 61 (7) 999-1005; DOI: https://doi.org/10.2967/jnumed.119.231621
You have access
¹⁸F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome
Anne-Ségolène Cottereau, Christophe Nioche, Anne-Sophie Dirand, Jérôme Clerc, Franck Morschhauser, Olivier Casasnovas, Michel Meignan and Irène Buvat

Journal of Nuclear Medicine January 1, 2020, 61 (1) 40-45; DOI: https://doi.org/10.2967/jnumed.119.229450
You have access
Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma
Constantin Lapa, Heribert Hänscheid, Malte Kircher, Andreas Schirbel, Gerd Wunderlich, Rudolf A. Werner, Samuel Samnick, Jörg Kotzerke, Hermann Einsele, Andreas K. Buck, Hans-Jürgen Wester and Götz Ulrich Grigoleit

Journal of Nuclear Medicine January 1, 2019, 60 (1) 60-64; DOI: https://doi.org/10.2967/jnumed.118.210997
You have access
Interobserver Agreement of Interim and End-of-Treatment ¹⁸F-FDG PET/CT in Diffuse Large B-Cell Lymphoma: Impact on Clinical Practice and Trials
Coreline N. Burggraaff, Alexander C. Cornelisse, Otto S. Hoekstra, Pieternella J. Lugtenburg, Bart De Keizer, Anne I.J. Arens, Filiz Celik, Julia E. Huijbregts, Henrica C.W. De Vet and Josée M. Zijlstra; on behalf of the HOVON Imaging Working Group

Journal of Nuclear Medicine December 1, 2018, 59 (12) 1831-1836; DOI: https://doi.org/10.2967/jnumed.118.210807

Main menu

User menu

Search

DLBCL